Search results
Samantha Ruth Prabhu accused of promoting unscientific therapies by 'Liver Doc' | - Times of India
The Times of India· 2 days agoSamantha Ruth Prabhu's latest post on the use of hydrogen peroxide nebulisation has not gone down...
Left in limbo: When pharma halts rare disease research
Pharmaceutical Technology· 5 days agoSimilarly, in April 2024, Great Ormond Street Hospital (GOSH) in the UK announced that it is...
Researchers find how physical exercise prevents nerve damage during chemotherapy - ET HealthWorld
The Economic Times· 5 days agoBasel: Damage to nerves brought on by cancer therapies frequently results in symptoms that endure a...
Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
Pharmaceutical Technology· 4 days agoAs Eli Lilly’s Kisunla (donanemab) enters the Alzheimer's treatment space, its leading competitor...
UniQure, with sale of plant, outsources Hemgenix manufacturing
BioPharma Dive· 6 days agoDive Brief: UniQure will sell a gene therapy production plant in Lexington, Massachusetts, to...
Strategies to address the viral vector manufacturing shortage
Pharmaceutical Technology· 6 days agoWith the exciting promise of addressing previously unmet medical needs, the rapidly growing field of...
Kerala transwoman forced to undergo conversion therapy gets HC relief
Hindustan Times· 4 days agoThe bench of justices Raja Vijayaraghavan V and PM Manoj held that LGBT persons like other...
Viral vector manufacturing: design considerations to improve commercial success
Pharmaceutical Technology· 6 days agoViral vector manufacturing: the key to the success of gene therapy Frost & Sullivan recently invited...
Budget 2024: Wishlist of the pharma industry
rediff.com· 3 hours agoThere is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order...
Orion to hand over exclusive rights to MSD for prostate cancer therapy
Pharmaceutical Technology· 6 days agoGlobalData is the parent company of Pharmaceutical Technology. The randomised, open-label OMAHA1...